Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors

Proteomics

Volumn 12, Issue 13, 2012, Pages 2158-2166

  Desiderio, Claudia ^a   D'Angelo, Luca ^b,c   Rossetti, Diana Valeria ^b   Iavarone, Federica ^b   Giardina, Bruno ^a,b   Castagnola, Massimo ^a,b   Massimi, Luca ^c   Tamburrini, Gianpiero ^c   Di Rocco, Concezio ^c  

^a CNR   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Biomarkers; Biomedicine; Brain tumors; Cerebrospinal fluid; Hemorphins

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HEMORPHIN 7; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER DIAGNOSIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; INFANT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEUROSURGERY; POSTERIOR FOSSA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; SCHOOL CHILD;

ADOLESCENT; AMINO ACID SEQUENCE; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRANIAL FOSSA, POSTERIOR; FEMALE; HEMOGLOBINS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864016034     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100499     Document Type: Article

References (31)

1. Choux, M., Di Rocco, C., Walker, M. L., Hockley, A. D., Pediatric Neurosurgery, Churchill Livingstone ed, London, Edinburgh, New York 1999.
2. Onvani, S., Etame, A. B., Smith, C. A., Rutka, J. T., Genetics of medulloblastoma: clues for novel therapies. Expert Rev. Neurother. 2010, 10, 811-823.
3. Ekegren, T., Hanrieder, J., Bergquist, J., Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research. J. Mass. Spectrom. 2008, 43, 559-571.
4. Khwaja, F. W., Reed, M. S., Olson, J. J., Schmotzer, B. J. et al., Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. J. Proteome. Res. 2007, 6, 559-570.
5. Xiao, F., Chen, D., Lu, Y., Xiao, Z. et al., Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy. Brain Res. 2009, 1255, 180-189.
6. Roy, S., Josephson, S. A., Fridlyand, J., Karch, J. et al., Protein biomarker identification in the CSF of patients with CNS lymphoma. J. Clin. Oncol. 2008, 26, 96-105.
7. Fjell, A. M., Walhovd, K. B., Fennema-Notestine, C., McEvoy, L. K. et al., CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J. Neurosci. 2010, 30, 2088-2101.
8. Zheng, P. P., Kros, J. M., Sillevis-Smitt, P. A., Luider, T. M., Proteomics in primary brain tumors. Front Biosci. 2003, 8, d451-d463.
9. Petrik, V., Loosemore, A., Howe, F. A., Bell, B. A. et al., OMICS and brain tumor biomarkers. Brit. J. Neurosurg. 2006, 20, 275-280.
10. Khwaja, F. W., Nolen, J. D., Mendrinos, S. E., Lewis, M. M. et al., Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers. Proteomics 2006, 6, 6277-6287.
11. Rajagopal, M. U., Hathout, Y., MacDonald, T. J., Kieran, M. W. et al., Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: a pediatric brain tumor consortium study. Proteomics 2011, 11, 935-943.
12. Castagnola, M., Inzitari, R., Fanali, C., Iavarone, F. et al., The surprising composition of the salivary proteome of preterm human newborn. Mol. Cell Proteomics 2011, 10, M110.003467.
13. Ivanov, V. T., Karelin, A. A., Philippova, M. M., Nazimov, I. V. et al., Hemoglobin as a source of endogenous bioactive peptides: the concept of tissue-specific peptide pool. Biopolymers 1997, 43, 171-188.
14. Giardina, B., Messana, I., Scatena, R., Castagnola, M., The multiple function of haemoglobin. Crit. Rev. Biochem. Mol. Biol. 1995, 30, 165-196.
15. Liepke, C., Baxmann, S., Heine, C., Breithaupt, N. et al., Human haemoglobin-derived peptides exhibited antimicrobial activity: a class of host defense peptides. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2003, 791, 345-346.
16. Zamyatnin, A. A. Hemoglobin as a potential source of natural regulatory oligopeptides. Biochemistry (Mosc). 2009, 74, 201-208.
17. Ohyagi, Y., Yamada, T., Goto, I., Hemoglobin as a novel protein developmentally regulated in neurons. Brain Res. 1994, 635, 323-327.
18. Richter, F., Meurers, B.H., Zhu, C., Medvedeva, V. P. et al., Neurons express hemoglobin alpha- and beta-chains in rat and human brains. J. Comp. Neurol. 2009, 515, 538-547.
19. Biagioli, M., Pinto, M., Cesselli, D., Zaninello, M., et al., Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc. Natl. Acad. Sci. USA 2009, 106, 15454-15459.
20. Gelman, J. S., Sironi, J., Castro, L. M., Ferro, E. S. et al., Hemopressins and other hemoglobin-derived peptides in mouse brain: comparison between brain, blood, and heart peptidome and regulation in Cpefat/fat mice. J. Neurochem. 2010, 113, 871-880.
21. Brantl, V., Gramsch, C., Lottspeich, F., Mertz, R. et al., Novel opioid peptides derived from hemoglobin: hemorphins. Eur. J. Pharmacol. 1986, 125, 309-310.
22. Nyberg, F., Sanderson, K., Glämsta, E. L., The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin. Biopolymers 1997, 43, 147-156.
23. Lammerich, H. P., Busmann, A., Kutzleb, C., Wendland, M. et al. Identification and functional characterization of hemorphins VV-H-7 and LVV-H-7 as low-affinity agonists for the orphan bombesin receptor subtype 3. Brit. J. Pharmacol. 2003, 138, 1431-1440.
24. Moeller, I., Albiston, A. L., Lew, R. A., Mendelsohn, F. A. et al., A globin fragment, LVV-hemorphin-7, induces [3H]thymidine incorporation in a neuronal cell line via the AT4 receptor. J. Neurochem. 1999, 73, 301-308.
25. Gelman, J. S., Fricker, L. D., Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?. AAPS J. 2010, 12, 279-289.
26. Cerpa-Poljak, A., Lahnstein, J., Mason, K. E., Smythe, G. A. et al., Mass spectrometric identification and quantification of hemorphins extracted from human adrenal and pheochromocytoma tissue. J. Neurochem. 1997, 68, 1712-1719.
27. Duethman, D., Dewan, N., Conlon, J. M., Isolation of the opioid peptide Leu-Val-Val-hemorphin-7 from bronchoalveolar lavage fluid of a patient with non-small cell lung cancer. Peptides 2000, 21, 137-142.
28. Blishchenko, E. Y., Sazonova, O. V., Kalinina, O. A., Yatskin, O. N. et al. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures. Peptides 2002, 23, 903-910.
29. Cohen, M., Fruitier-Arnaudin, I., Sauvan, R., Birnbaum, D. et al., Serum levels of Hemorphin-7 peptides in patients with breast cancer. Clin. Chim. Acta. 2003, 337, 59-67.
30. Fruitier, I., Garreau, I., Piot, J. M., Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7. Biochem. Biophys. Res. Commun. 1998, 246, 719-724.
31. Murillo, L., Piot, J. M., Coitoux, C., Fruitier-Arnaudin, I., Brain processing of hemorphin-7 peptides in various subcellular fractions from rats. Peptides 2006, 27, 3331-3340.